Inherited susceptibility to aminoglycoside ototoxicity: Genetic heterogeneity and clinical implications

This publication has 12 references indexed in Scilit:

• Familial Progressive Sensorineural Deafness Is Mainly Due to the mtDNA A1555G Mutation and Is Enhanced by Treatment with Aminoglycosides
  American Journal of Human Genetics, 1998
• Mitochondrial gene mutation is a significant predisposing factor in aminoglycoside ototoxicity
  American Journal of Otolaryngology, 1997
• Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity.
  Journal of Medical Genetics, 1997
• Two large Spanish pedigrees with nonsyndromic sensorineural deafness and the mtDNA mutation at nt 1555 in the 12S rRNA gene
  Neurology, 1997
• Non-Syndromic Deafness Associated with a Mutation and a Polymorphism in the Mitochondrial 12S Ribosomal RNA Gene in a Large Zairean Pedigree
  European Journal of Human Genetics, 1996
• Mitochondrial mutation associated with nonsyndromic deafness
  American Journal of Otolaryngology, 1995
• Susceptibility mutations in the mitochondrial small ribosomal RNA gene in aminoglycoside induced deafness
  Pharmacogenetics, 1995
• Mitochondrial DNA Variants Observed in Alzheimer Disease and Parkinson Disease Patients
  Genomics, 1993
• Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafness
  Nature Genetics, 1993
• A Molecular basis for human hypersensitivity of aminoglyscoside antibiotics
  Nucleic Acids Research, 1993